Plasticity in zwitterionic drugs: the bending properties of Pregabalin and Gabapentin and their hydrates
Source abstract
Abstract
The investigation of mechanical properties in molecular crystals is emerging as a novel area of interest in crystal engineering. Indeed, good mechanical properties are required to manufacture pharmaceutical and technologically relevant substances into usable products. In such endeavour, bendable single crystals help to correlate microscopic structure to macroscopic properties for potential design. The hydrate forms of two anticonvulsant zwitterionic drugs, Pregabalin and Gabapentin, are two examples of crystalline materials that show macroscopic plasticity. The direct comparison of these structures with those of their anhydrous counterparts, which are brittle, suggests that the presence of water is critical for plasticity. In contrast, structural features such as molecular packing and anisotropic distribution of strong and weak interactions seem less important.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Crystallography and molecular interactions · Supramolecular Chemistry and Complexes · Crystallization and Solubility Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (44)
Show source-provided references
1. Alimi · Chem. Commun. · 2018 · 54 · 299410.1039/C8CC00775F ↗
2. Bajpai · IUCrJ · 2016 · 3 · 43010.1107/S2052252516015633 ↗
3. Barbour · J. Supramol. Chem. · 2001 · 1 · 18910.1016/S1472-7862(02)00030-8 ↗
4. Braga · Eur. J. Inorg. Chem. · 2018 · 2018 · 359710.1002/ejic.201800234 ↗
5. Braga · New J. Chem. · 2008 · 32 · 178810.1039/b809662g ↗
6. Chang · Mol. Pharm. · 2017 · 14 · 204710.1021/acs.molpharmaceut.7b00124 ↗
7. Corpinot · Cryst. Growth Des. · 2019 · 19 · 142610.1021/acs.cgd.8b00972 ↗
8. Desiraju, G. R. (1989). Crystal Engineering: The Design of Organic Solids. Amsterdam: Elsevier.
9. Ding · Acta Cryst. B · 1991 · 47 · 73910.1107/S0108768191004500 ↗
10. Dunitz · Trans. Am. Cryst. Assoc. · 1984 · 20 · 1
11. Etter · Acc. Chem. Res. · 1990 · 23 · 12010.1021/ar00172a005 ↗
12. Etter · J. Am. Chem. Soc. · 1983 · 105 · 64110.1021/ja00341a065 ↗
13. Fucke · Cryst. Growth Des. · 2012 · 12 · 139510.1021/cg201499s ↗
14. Groom · Acta Cryst. B · 2016 · 72 · 17110.1107/S2052520616003954 ↗
15. Ibers · Acta Cryst. C · 2001 · 57 · 64110.1107/S0108270101003341 ↗
16. Infantes · CrystEngComm · 2002 · 4 · 45410.1039/b204934a ↗
17. Krishna · J. Am. Chem. Soc. · 2016 · 138 · 1356110.1021/jacs.6b05118 ↗
18. Liu · Chem. Mater. · 2018 · 30 · 379810.1021/acs.chemmater.8b00939 ↗
19. Lusi · CrystEngComm · 2018 · 20 · 704210.1039/C8CE00691A ↗
20. Lusi · Chem. Commun. · 2013 · 49 · 263410.1039/c3cc40521d ↗
21. Mascal · Angew. Chem. Int. Ed. · 2006 · 45 · 3210.1002/anie.200501839 ↗
22. Moulton · Chem. Rev. · 2001 · 101 · 162910.1021/cr9900432 ↗
23. Nath · J. Mol. Struct. · 2018 · 1160 · 2010.1016/j.molstruc.2018.01.044 ↗
24. Naumov · Chem. Rev. · 2015 · 115 · 1244010.1021/acs.chemrev.5b00398 ↗
25. Rao Khandavilli · Chem. Commun. · 2017 · 53 · 338110.1039/C7CC01091E ↗
26. Reddy · Chem. Commun. · 2005 · 44 · 243910.1039/b500712g ↗
27. Reddy, C. M., Gundakaram, R. C., Basavoju, S., Kirchner, M. T., Padmanabhan, K. A. & Desiraju, G. R. (2005b). Chem. Commun. 0, 3945-3947.10.1039/b505103g ↗
28. Reddy · Chem. Eur. J. · 2006 · 12 · 222210.1002/chem.200500983 ↗
29. Reddy · Cryst. Growth Des. · 2006 · 6 · 272010.1021/cg060398w ↗
30. Reddy · CrystEngComm · 2010 · 12 · 229610.1039/c003466e ↗
31. Reece · Acta Cryst. C · 2008 · 64 · o10510.1107/S0108270107066279 ↗
32. Reilly · Acta Cryst. B · 2016 · 72 · 43910.1107/S2052520616007447 ↗
33. Saha · Chem. Commun. · 2017 · 53 · 637110.1039/C7CC02970E ↗
34. Saha · Acc. Chem. Res. · 2018 · 51 · 295710.1021/acs.accounts.8b00425 ↗
35. Steiner · Acta Cryst. B · 1993 · 49 · 70810.1107/S0108768193000795 ↗
36. Sun · Pharm. Res. · 2004 · 21 · 38210.1023/B:PHAM.0000016272.81390.b4 ↗
37. Takamizawa · Angew. Chem. Int. Ed. · 2014 · 53 · 697010.1002/anie.201311014 ↗
38. Takamizawa · Nat. Commun. · 2018 · 9 · 398410.1038/s41467-018-06431-7 ↗
39. Thomas · Angew. Chem. · 2017 · 129 · 858810.1002/ange.201701972 ↗
40. Thoorens · Int. J. Pharm. · 2015 · 490 · 4710.1016/j.ijpharm.2015.05.026 ↗
41. Vasudev · Chem. Biol. Drug Des. · 2009 · 73 · 8310.1111/j.1747-0285.2008.00726.x ↗
42. Venu · Acta Cryst. C · 2007 · 63 · o30610.1107/S0108270107016952 ↗
43. Wang · J. Chem. Thermodyn. · 2017 · 113 · 13210.1016/j.jct.2017.05.041 ↗
44. Zamir · Mol. Cryst. Liq. Cryst. · 1994 · 242 · 19310.1080/10587259408037751 ↗